Indication
Reduction of intraocular pressure (IOP) in patients with open angle glaucoma and ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.

Medicine details

Medicine name:
latanoprost + timolol (Fixapost)
SMC ID:
SMC2159
Pharmaceutical company
Thea Pharmaceuticals
BNF chapter
Submission type
Abbreviated
Status
Advice due date:
13 May 2019
SMC meeting date:
02 April 2019